WeissLaw LLP Investigates Intermolecular, Inc. Acquisition

Date : 05/16/2019 @ 2:01AM
Source : PR Newswire (US)
Stock : Intermolecular, Inc. (IMI)
Quote : 1.17  0.01 (0.86%) @ 12:53AM
Intermolecular, Inc. share price Chart

WeissLaw LLP Investigates Intermolecular, Inc. Acquisition

Intermolecular, Inc. (NASDAQ:IMI)
Historical Stock Chart

1 Month : From Apr 2019 to May 2019

Click Here for more Intermolecular, Inc. Charts.

NEW YORK, May 15, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Intermolecular, Inc. ("Intermolecular" or the "Company") (NASDAQ: IMI) in connection with the proposed acquisition of the Company by a wholly owned subsidiary of Merck KGaA.  Under the terms of the acquisition agreement valued at $62 million, shareholders will receive $1.20 per share in cash. 

WeissLaw LLP (PRNewsfoto/WeissLaw LLP)

If you own IMI shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, please contact:

Joshua Rubin
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY  10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

Visit our website
http://www.weisslawllp.com/

Or follow us on Twitter @MarketsAlert

WeissLaw is investigating whether Intermolecular's Board acted to maximize shareholder value prior to entering into the agreement. 

WeissLaw is concentrating its investigation on whether Intermolecular's Board conducted a fair process in agreeing to the proposed acquisition, and whether the proposed acquisition undervalues the Company. 

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases.  If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at stockinfo@weisslawllp.com.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/weisslaw-llp-investigates-intermolecular-inc-acquisition-300851308.html

SOURCE WeissLaw LLP

Copyright 2019 PR Newswire

Latest IMI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20190519 17:01:39